More recent works using immunodeficient mouse strains with defects in performin, interferon gamma, recombination activating gene (Rag2), signal transducer, and activator of transcription 1 (Stat1), and other genes reported an increased cancer incidence; however, the distribution of cancer resembled that observed in humans with PID. This evidence concerns the gene IFNG and cancer.